Clovis Oncology
CLVS
$0.08120
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)
Categories
Clovis Oncology (CLVS) - Total assets
Total assets on the balance sheet as of September 2022 : $0.34 B
According to Clovis Oncology's latest financial reports the company's total assets are $0.34 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Clovis Oncology - Total assets on balance sheet (from 2010 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | $0.47 B | -21.92% |
| 2020-12-31 | $0.60 B | -9.57% |
| 2019-12-31 | $0.66 B | -22.46% |
| 2018-12-31 | $0.86 B | 17.45% |
| 2017-12-31 | $0.73 B | 101.68% |
| 2016-12-31 | $0.36 B | -48.9% |
| 2015-12-31 | $0.71 B | -9.26% |
| 2014-12-31 | $0.78 B | 21.02% |
| 2013-12-31 | $0.64 B | 344.97% |
| 2012-12-31 | $0.14 B | 1.78% |
| 2011-12-31 | $0.14 B | 447.5% |
| 2010-12-31 | $26.2 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 48,218.94% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 65,216.42% | 🇺🇸 USA |
 AbbVie ABBV | $134.71 B | 38,746.80% | 🇺🇸 USA |
 Eli Lilly LLY | $64.00 B | 18,357.59% | 🇺🇸 USA |
 AstraZeneca AZN | $102.29 B | 29,398.38% | 🇬🇧 UK |
 BioMarin Pharmaceutical BMRN | $6.84 B | 1,872.92% | 🇺🇸 USA |